INCREASED SENSITIVITY OF ESCHERICHIA-COLI TO NOVOBIOCIN, EDTA AND THEANTICALMODULIN DRUG W7 FOLLOWING OVERPRODUCTION OF DJLA REQUIRES A FUNCTIONAL TRANSMEMBRANE DOMAIN
S. Bernard et al., INCREASED SENSITIVITY OF ESCHERICHIA-COLI TO NOVOBIOCIN, EDTA AND THEANTICALMODULIN DRUG W7 FOLLOWING OVERPRODUCTION OF DJLA REQUIRES A FUNCTIONAL TRANSMEMBRANE DOMAIN, MGG. Molecular & general genetics, 259(6), 1998, pp. 645-655
In earlier studies we found that E. coli is sensitive to anticalmoduli
n drugs such as W7. Mutants that are resistant to this drug were isola
ted, including wseA1. In an attempt to clone the wseA gene, we isolate
d a clone that restored sensitivity to the drug in the mutant. We foun
d that this clone in fact suppresses W7 resistance through expression
of djlA, which encodes a novel DnaJ-like protein. It was found previou
sly that overproduction of DjlA could induce capsule synthesis via act
ivation of the two-component regulatory pathway RcsC/B. In addition to
suppression of wseAl, djlA overexpression increases the sensitivity o
f cells to EDTA and novobiocin, but not to other drugs tested. Althoug
h overexpression of a form of the protein carrying a mutation in, or l
acking, the J-region of DjlA also led to increased sensitivity, indica
ting that the chaperone activity of this protein was not strictly requ
ired, the full-length, wild- type protein had a more pronounced effect
. In contrast, a point mutation which affects the function of the tran
smembrane domain but not the localisation or stability of DjlA abolish
ed the effects of DjlA overproduction.